Iatrogenic Botulism Following Botulinum Toxin Injection in a Child With Cerebral Palsy: A Case Report.

Journal of child neurology 2026 Vol.41(5) p. 747-750

Öztürk S, Sütbeyaz ST, Per H

관련 도메인

Abstract

BackgroundBotulinum toxin is widely used for the treatment of spasticity in pediatric patients with cerebral palsy. Although regarded as safe, rare but severe systemic complications, such as iatrogenic botulism, may arise.Case PresentationWe present the case of an 8-year-old boy with cerebral palsy who experienced global muscle weakness, bilateral ptosis, dysphagia, and respiratory distress after botulinum toxin A (Dysport). The clinical presentation was consistent with iatrogenic botulism. The patient was administered botulinum antitoxin, resulting in a gradual enhancement of the condition. Sequential clinical photos depict the progression of the sickness and subsequent recovery, which led to progressive improvement.ConclusionIatrogenic botulism must be contemplated in individuals exhibiting new-onset bulbar or respiratory symptoms after botulinum toxin injection. Timely identification and prompt commencement of antitoxin treatment are essential for positive outcomes.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 3
시술 dysport 보툴리눔독소 주사 dict 1
해부 Cerebral scispacy 1
해부 muscle scispacy 1
질환 Botulism C0006057
Botulism
scispacy 1
질환 Cerebral Palsy C0007789
Cerebral Palsy
scispacy 1
질환 spasticity C0026838
Muscle Spasticity
scispacy 1
질환 muscle weakness C0030552
Paresis
scispacy 1
질환 ptosis, dysphagia scispacy 1
질환 respiratory distress C0476273
Respiratory distress
scispacy 1
기타 patients scispacy 1
기타 boy scispacy 1
기타 patient scispacy 1
기타 antitoxin scispacy 1

MeSH Terms

Humans; Child; Male; Cerebral Palsy; Botulism; Botulinum Toxins, Type A; Iatrogenic Disease; Neuromuscular Agents; Botulinum Antitoxin

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문